The correlation of beta-subunit human chorionic gonadotropin level in the serum and first morning urine of patients with gestational trophoblastic disease.

The purpose of this cross-sectional study was to determine the correlation of beta subunit human chorionic gonadotropin (beta-hCG) level in the serum and first morning urine samples of patients with gestational trophoblastic disease (GTD). A total of 81 paired serum and first morning urine samples from 24 patients diagnosed with GTD, who had their follow-up at the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University. The paired serum and first morning urine samples were measured for beta-hCG level, using enzyme-linked immunosorbent assay (ELISA). After logarithmic transformation, serum beta-hCG level was strongly and significantly correlated to those of first morning urine samples, with the correlation coefficient of 0.97 (p < 0.01). Among the disease-remission group (serum beta-hCG of less than 5 mIU/ml), the correlation coefficient was 0.52 (p < 0.01), which was still statistically significant. Stronger statistical significance was found in the disease-active group (serum beta-hCG of 5 mIU/ml or higher), with the correlation coefficient of 0.95 (p < 0.01). We concluded that the level of serum beta-hCG was strongly and significantly correlated with those of first morning urine samples, especially in patients with active disease. Determination of beta-hCG level using first morning urine samples can be used as an effective mean in the follow-up of patients with GTD.

Benign cystic teratoma of the ovary : a review of 608 patients.

This retrospective study reports on 608 cases of benign cystic teratoma of the ovary treated at Siriraj Hospital over a ten-year period from 1988-1997. Mean age of the patients was 33.7 + 11.3 years. Approximately one-third of the patients (35.0%) were asymptomatic when the teratomas were discovered, of the rest, the common presenting symptoms were abdominal pain (52.9%) or palpable abdominal mass (30.6%). The tumors were between 6-10 cm in greatest diameter in more than half of the patients (53.6%) and in 78 patients (12.8%), the tumors were bilateral. Complications from the tumors were found in 72 patients (11.8%): 68 cases of torsion (94.4%); two were spontaneous rupture (2.8%); and two were infected (2.8%). The mean age of patients with twisted tumor was significantly less than that of patients with uncomplicated tumor (p = 0.02), and abdominal pain was found more commonly in the patients with twisted tumor (p < 0.001). Among cases with torsion, more than 90 per cent of the tumors were found to be of intermediate size (6-15 cm), while only 68.8 per cent were found in uncomplicated cases (p < 0.001). Surgical treatment was conservative in 63.8 per cent) and radical in 36.2 per cent of the patients.

Prevalence of cytomegalovirus antibodies among various age groups of Thai population.

The prevalence of CMV antibody in various groups of Thai population was studied. Pregnant women and young children had been infected with CMV more than the other studied groups. Children of both sex had equal chance of getting CMV infection while the risk of CMV infection in adult between male and female was significantly difference (p < 0.001). Pregnant women had higher chance to get CMV infection than normal women. Prevalence of CMV antibody at present was similar to previous studies.

The use of lenograstim (Granocyte) in chemotherapy for ovarian cancer.

We have conducted an open, controlled study on the febrile neutropenia effects by Lenograstim (Granocyte) therapy following cytotoxic chemotherapy of cisplatinum and cyclophosphamide in patients with primary advanced epithelial ovarian cancer. Eligible patients (n = 17) were divided into 2 groups receiving a combined chemotherapy of intravenous cisplatinum (70 mg/m2) and cyclophosphamide (700 mg/m2) with or without the addition of Lenograstim. Subcutaneous administration of Lenograstim (100 micrograms/day) for 7 consecutive days was given from day 8 to day 14 of the 3rd to the 5th cycle of chemotherapy in Lenograstim treated patients. After 3 cycles of treatment, Lenograstim treated patients (group 1, n = 10) showed a significant improvement in white blood cell (WBC) count as compared with group 2 (control) of 7 patients (p = 0.00002). Group 1 patients also showed an increased C-reactive protein, though of no significance. There were no significant differences among the 2 groups regarding ESR, hematocrit, platelet counts and blood chemistry profiles. This preliminary data encourages more study of the benefits of Lenograstim in the treatment of ovarian cancer.

The study of HCV antibody and serologic tests for syphilis in Thai patients with gynecologic disorders.

Investigation for prevalence of antibodies to hepatitis C virus (HCV) and to Treponema pallidum was conducted in 883 females with gynecologic disorders who were admitted to the gynecological ward of the Department of Obstetrics and Gynecology, Siriraj Hospital during April to August 1991. The study population consisted of 678 patients with malignancies and 205 patients with benign diseases. Anti-HCV antibody was found in 3.1% of the cases with malignancies and 1.46% of those with benign diseases. Among the gynecologic malignant group, the patients with carcinoma of cervix had the highest prevalence of HCV antibody (3.6%). The positive serologic tests for syphilis in patients with carcinoma of cervix (9.8%) were significantly higher from those in patients with ovarian carcinoma (3.75%) (p < 0.01). There were 3 cases with carcinoma of cervix who were simultaneously sero-positive for both HCV and syphilis.